Earnings6 reported quarters · next on Jan 28, 2027
Earnings
Quarter
EPS
EPS expected
Revenue
Revenue expected
Result
Q3 FY2026reported Oct 20, 2026
$3.00
$2.65
$3.0B
$2.9B
EPS beatRevenue beat
Q2 FY2026reported Jul 16, 2026
$2.80
$2.51
$2.9B
$2.8B
EPS beatRevenue beat
Q1 FY2026reported Apr 21, 2026
$2.80
$2.51
$2.8B
$2.6B
EPS beatRevenue beat
Q4 FY2025reported Jan 22, 2026
$2.53
$2.27
$2.9B
$2.8B
EPS beatRevenue beat
Q3 FY2025reported Oct 21, 2025
$2.40
$1.99
$2.5B
$2.4B
EPS beatRevenue beat
Q2 FY2025reported Jul 22, 2025
$2.19
$1.93
$2.4B
$2.4B
EPS beatRevenue beat
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Written by GetSignal with AI from each earnings call; every brief quotes the executives' own words. Key facts are what the company said on the call, not our forecast. Not investment advice.
Each firm's latest price target on ISRG, newest first
Firm
Rating
Target
Action
Date
Leerink
Outperform
$503
Target set
RBC Capital
Outperform
$550
Target set
Oppenheimer
Outperform
$500
Target set
Baird
Outperform
$550
Target set
Wells Fargo
Overweight
$486
Cut from $487
Barclays
Overweight
$500
Raised from $485
Raymond James
Outperform
$480
Cut from $483
Mizuho
Neutralrated Oct 21, 2026
$415
Raised from $400
BTIG
Buy
$454
Cut from $469
HSBC
Hold
$391
Target set
UBS
Buy
$500
Target set
Stifel
Buy
$550
Cut from $670
Truist Securities
Buy
$510
Cut from $580
BMO Capital
Outperform
$518
Initiated
Evercore ISI
In Line
$430
Target set
Goldman Sachs
Not stated
$558
Target set
Bernstein
Outperform
$750
Raised from $740
Each firm's latest target from the past year, with the rating stated with its note. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice. A rating with its own date under it is the firm's latest from the past 120 days, where the note stated none.
7 other firms rated ISRG in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 12, 2026.
Proxy statementas filed for fiscal 2025 · proxy filed Mar 13, 2026
Executive pay
David J. Rosa’s pay as CEO came to $21.0M for fiscal 2025.
Executive
Salary
Stock awards
Other
Total
David J. RosaChief Executive Officer
$859K
$18.7M
$1.5M
$21.0M
Gary S. Guthart, Ph.D.Executive Chair of the Board of Directors
$866K
$16.0M
$1.3M
$18.1M
Jamie E. SamathExecutive Vice President, Chief Financial Officer and Enterprise Technology Leader
$683K
$6.9M
$799K
$8.4M
Henry L. CharltonExecutive Vice President and Chief Commercial and Marketing Officer
$670K
$4.8M
$784K
$6.2M
Gary H. LoebExecutive Vice President and Chief Legal and Compliance Officer
$615K
$4.3M
$720K
$5.6M
Mark P. BrosiusSenior Vice President and Chief Manufacturing and Supply Chain Officer
$534K
$4.5M
$484K
$5.5M
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
13F filings13F positions as of Jun 30, 2026
Institutional holders
2,263 institutions reported Intuitive Surgical shares in 13F filings for Jun 30, 2026.
Holder
Value
Shares
Shares vs prior qtr
% of shares out
BlackRock, Inc.
$11.9B
30,024,648
-0.2%
8.47%
Vanguard Capital Management LLC
$9.2B
23,131,099
+0.2%
6.53%
State Street Corp
$6.4B
16,063,040
+1.4%
4.53%
Invesco Ltd.
$4.7B
11,843,563
+58.9%
3.34%
T. Rowe Price Associates, Inc.
$4.5B
11,256,570
-10.1%
3.18%
Geode Capital Management, LLC
$3.4B
8,534,767
+0.8%
2.41%
Capital World Investors
$3.1B
7,742,681
-3.8%
2.18%
Vanguard Portfolio Management LLC
$2.9B
7,243,264
+0.1%
2.04%
Morgan Stanley
$2.6B
6,561,322
+8.3%
1.85%
Norges Bank
$2.0B
4,954,874
New
1.40%
JPMorgan Chase & Co.
$1.7B
4,231,033
-7.9%
1.19%
FMR LLC
$1.7B
4,251,130
-22.4%
1.20%
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. New: not in this holder's prior 13F as reported; a change of filer ID can also show as new. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
7 of the 97 fund managers we track list ISRG shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Other Form 4 activity (20)
Insider
Event
Shares
Date
Craig H. BarrattDirector
Option exercise
1,150
Nov 4, 2026
Fredrik WidmanVP Corporate Controller
Option exercise
3,531
Oct 30, 2026
Craig H. BarrattDirector
Option exercise
1,150
Oct 23, 2026
Fredrik WidmanVP Corporate Controller
Option exercise
2,442
Oct 23, 2026
Patricia L. WadorsSVP Chief Human Resources Offi
Tax withholding
1,062
Oct 10, 2026
Patricia L. WadorsSVP Chief Human Resources Offi
Option exercise
2,140
Oct 10, 2026
Gary LoebEVP & Chief Legal and Complian
Tax withholding
1,296
Oct 10, 2026
Gary LoebEVP & Chief Legal and Complian
Option exercise
2,612
Oct 10, 2026
Fredrik WidmanVP Corporate Controller
Option exercise
1,089
Sep 15, 2026
David J. RosaChief Executive Officer (CEO)
Tax withholding
947
Jul 10, 2026
David J. RosaChief Executive Officer (CEO)
Option exercise
1,910
Jul 10, 2026
David J. RosaChief Executive Officer (CEO)
Tax withholding
674
Jun 10, 2026
David J. RosaChief Executive Officer (CEO)
Option exercise
1,358
Jun 10, 2026
Iman JeddiSVP & GM Da Vinci Platforms &
Option exercise
5,625
Jun 1, 2026
Gary S. GuthartDirector
Stock award
554
Apr 30, 2026
Craig H. BarrattDirector
Stock award
643
Apr 30, 2026
Craig H. BarrattDirector
Option exercise
750
Apr 30, 2026
Joseph C. BeeryDirector
Stock award
554
Apr 30, 2026
Joseph C. BeeryDirector
Option exercise
531
Apr 30, 2026
Lewis ChewDirector
Stock award
554
Apr 30, 2026
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
STOCK Act20 disclosures of 210 on record · median 20d of the 45 allowed
Congress trades in ISRG
Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
-10.2%since the saleEstimated exit price $500.76, close on Wed Feb 18Current price $449.53, close on Wed Nov 11
Feb 18, 2026
Mar 9, 2026
19d
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
The largest estimated position is in the $15,001 - $50,000 band. Estimate, as of Nov 12, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
On Form 4, code P is an open-market purchase and S an open-market sale; a sale marked scheduled was set up in advance under a Rule 10b5-1 plan. Awards, option exercises, tax withholding and gifts (A, M, F and G) are listed under Other Form 4 activity and never counted as either.
A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.
What the filings on ISRG show and how current they are.
Are insiders buying or selling ISRG?
Across the 20 most recent open-market filings shown here, 0 were purchases and 20 were sales. 20 were scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress have traded ISRG?
Ro Khanna and Alan Armstrong disclosed ISRG transactions in the filings shown here.
Which members of Congress hold ISRG?
6 members of Congress report a position in ISRG in the estimate we hold as of Nov 12, 2026. The largest estimated position belongs to Gilbert Ray Cisneros, Jr.; the next largest, in the $1,001 - $15,000 band, include Josh Gottheimer and Lucy McBath. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is ISRG in the S&P 500 or the Nasdaq 100?
Intuitive Surgical, Inc. is a current member of the S&P 500 and Nasdaq 100, per the membership list we hold as of Nov 12, 2026. Current members of either index get a page here whatever their filing history.
How quickly are ISRG trades disclosed?
Insider filings on this page reached the public a median of 1 business day after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 20 days, against the 45 the STOCK Act allows.